EP3302477

PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    27.5.2016
  • :
    7.2.2024
  • :
    16799432.6
  • :
    26.5.2036
  • :
    PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER

27.5.2016
7.2.2024
  • :
    Lumosa Therapeutics Co., Ltd.
  • :
    4F No. 3-2 Park Street Nangang District, Taipei 11503, TW
  • :
    Shanghai Lumosa Therapeutics Co., Ltd.
  • :
    Room 3026, 3rd Floor, Building 1 No. 146, 1st East Fute Road Shanghai Pilot Free Trade Zone, Shanghai 200131, CN
  • :
    LI, Chan-Jung
  • :
    Taipei 11503, TW
  • :
    CHOU, David, Chih-Kuang
  • :
    Palo Alto, CA 94306, US
  • :
    HUANG, Jin-Ding
  • :
    Taipei 11503, TW
  • :
    TSAI, Shin, Jr.
  • :
    New Taipei City 235, TW
  • :
    KUO, Shu-Wen
  • :
    Taipei 11503, TW
  • :
    TIEN, Yu-En
  • :
    Taipei 11503, TW
  • :
    201514723996
  • :
    28.5.2015
  • :
    US
  • :
    201562255805 P
  • :
    16.11.2015
  • :
    US
  • :
    IB2016000857
  • :
    27.5.2016
  • :
    A61K 31/485, A61K 9/08, A61K 47/14, A61K 47/44, A61P 25/04